Your session is about to expire
← Back to Search
Aspirin for Ankle Fracture Healing
Phase < 1
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Over 18 years of age
Be older than 18 years old
Must not have
History of bleeding disorder
Pilon fractures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 - 12 months following surgery
Awards & highlights
No Placebo-Only Group
Summary
This trial will help to identify if taking aspirin after surgery to fix a fracture delays healing.
Who is the study for?
Adults over 18 with a recent ankle fracture requiring surgery can join this trial. They must be healthy enough for orthopedic surgery and able to consent. Excluded are those with multiple fractures, aspirin allergies, bleeding disorders, or on blood thinners.
What is being tested?
The study is testing if taking aspirin after ankle fracture surgery affects how quickly the bone heals. It's important because while NSAIDs are usually avoided due to concerns they may slow healing, many people take aspirin for other health issues.
What are the potential side effects?
Aspirin may cause side effects like stomach pain, heartburn, nausea, increased risk of bleeding and bruising. Rarely it can lead to severe allergic reactions or significant gastrointestinal problems.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of bleeding disorders.
Select...
I have a broken shinbone near my ankle.
Select...
I cannot take aspirin due to a specific health reason.
Select...
I have been taking aspirin before joining this study.
Select...
I am unable to understand and give consent for treatment.
Select...
I am under 18 years old.
Select...
I have had multiple broken bones from an injury.
Select...
I am on blood-thinning medication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 - 12 months following surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 - 12 months following surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Ankle Fracture Healing
Secondary study objectives
Functional Outcomes
Visual Analog Scale for Pain
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AspirinExperimental Treatment1 Intervention
250 patients will be randomized to receive Aspirin postoperatively.
Group II: Non-AspirinActive Control1 Intervention
250 patients will be randomized to not receive Aspirin postoperatively.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aspirin
2014
Completed Phase 4
~55580
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,341,884 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of bleeding disorders.I have a broken shinbone near my ankle.You have had a serious reaction to aspirin in the past.I cannot take aspirin due to a specific health reason.I have been taking aspirin before joining this study.I am unable to understand and give consent for treatment.I have a broken ankle of any type.I am under 18 years old.I have had multiple broken bones from an injury.I am fit for orthopedic surgery.You are allergic to aspirin.I am on blood-thinning medication.I am scheduled for ankle fracture surgery at UAB.I am over 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Aspirin
- Group 2: Non-Aspirin
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger